This is a consensus. With every breakthrough in cancer treatment and diagnosis research, we are one step closer to ridding ourselves of this disease.
But any news is good news, isn’t it?
According to Medical News Today, the world is one step closer to developing a widespread Saliva test for identifying and tracking lung cancer. It is also suggested that the same breakthrough could mean a step towards identification and tracking of cancers of the mouth and back of throat.
In their article, Medical News Today writes that researcher Prof. David Wong– leading a collaborative study between the UCLA and West China Hospital of Sichuan University– and team have been working on a method called “liquid biopsy” that detects circulating tumor DNA in bodily fluids such as saliva and blood.
A prototype has been developed which would put this method into effect– the device uses electric field-induced release and measurement (EFIRM) to detect non-small cell lung cancer (NSCLC) biomarkers in saliva. The EFIRM device would analyze the contents of exosomes and carry out a type of bio-recognition, which is reportedly much more accurate than current sequencing technologies afford.
This means: Quick, accurate and non-invasive lung cancer diagnoses in the near future?
The trial in lung cancer patients is reported to start in China this year.
More details are available on the article.